CoreWeave, Inc.·4

Jun 2, 8:06 PM ET

Cogen Jack D 4

Research Summary

AI-generated summary

Updated

CoreWeave (CRWV) Director Jack D. Cogen Sells Shares

What Happened

  • Jack D. Cogen, a director of CoreWeave, sold a total of 271,153 shares in open-market/private sales on May 29, 2026, generating roughly $29.0 million in proceeds. The filing shows four lots:
    • 90,410 shares at a weighted average price of $106.30 (proceeds $9,610,484; prices in range $105.75–$106.74)
    • 161,852 shares at a weighted average price of $107.19 (proceeds $17,348,268; prices in range $106.75–$107.71)
    • 16,923 shares at a weighted average price of $108.24 (proceeds $1,831,779; prices in range $107.885–$108.78)
    • 1,968 shares at a weighted average price of $108.82 (proceeds $214,163; prices in range $108.8050–$108.88)
  • These are sales (S) — not purchases or option exercises. Sales are common for insiders and do not by themselves indicate company performance.

Key Details

  • Transaction date: May 29, 2026; Form 4 filed June 2, 2026 (filed within the two-business-day window).
  • Aggregate shares sold: 271,153; aggregate proceeds: ~$29.00 million.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: reported securities are held across multiple trusts/LLCs and family accounts (e.g., Chestnut Tree Trust LLC; Cogen Family Trust; Jack D. Cogen 2020 Family Trust; Maple/Pine/Willow/Birch Tree Trust LLCs; CW Holding 987 LLC; spouse-held accounts; Cherry Tree 2024 GRAT). The filer disclaims beneficial ownership of certain entity-held securities except to the extent of any pecuniary interest (see footnote F2).
  • Pricing notes: each lot’s price is a weighted average; the filing provides the price ranges for the multiple transactions (see footnotes F1, F4, F5, F6).

Context

  • These were open-market/private sales by a director and involved shares held in various family/manager-controlled trusts and LLCs. Such dispositions often reflect personal or estate/portfolio management rather than a direct statement about company prospects. No option exercises, awards, or gifts were reported in this filing.